-
1
المؤلفون: Garau, J, Twynholm, M, Garcia Mendez, E, Siquier, B, Rivero, A, 557 Clinical Study Group, Aguilar, L, Almirante, B, Blanquer, R, Bouza, E, Caminero, J, Custardoy, J, De la Torre, J, Fernández Funcia, M, Gil, A, Gomez, J, Gómez, L, Juárez, S, Llorca, E, Molinos, L, Moreno, S, Muniain, Ma, Pachón, J, Pallarés, R, Pascual, M, Sánchez, J, Santos, J, Vidal, J, Viejo, Jl, Zubillaga, G, Beghi, G, Cacciani, S, Cattaneo, C, Cogo, R, Concia, Ercole, Dal Negro, R, Giosue, S, Giuntini, C, Raineri, M, Sutti, F, Talmasson, G, Tassi, G, Todisco, T, Richard, Mp
المصدر: The Journal of antimicrobial chemotherapy. 52(5)
مصطلحات موضوعية: Microbiology (medical), Adult, Male, medicine.medical_specialty, Adolescent, Population, medicine.disease_cause, Amoxicillin-Potassium Clavulanate Combination, Gastroenterology, Community-acquired pneumonia, Double-Blind Method, Clavulanic acid, Internal medicine, Streptococcus pneumoniae, medicine, Humans, Pharmacology (medical), Adverse effect, education, Antibacterial agent, Aged, Pharmacology, Aged, 80 and over, education.field_of_study, Antimicrobials, business.industry, Antimicrobials, CAP, Streptococcus pneumoniae, Amoxicillin, Middle Aged, Pneumonia, Pneumococcal, medicine.disease, CAP, Surgery, Penicillin, Community-Acquired Infections, Infectious Diseases, Treatment Outcome, Drug Therapy, Combination, Female, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d84adc5fd3b3d5a56f48b278eda1cea0
https://pubmed.ncbi.nlm.nih.gov/14563899